Skip to content
10-K

Annual Report

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

0001091818-26-000047

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 14, 2026 33.52M sh
Shares Diluted FY 2025 · Dec 31, 2025 33.21M sh
Shares Diluted FY 2025 · Dec 31, 2024 29.27M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$65.15K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$61.25K
Cash And Equivalents FY 2025 · Dec 31, 2025 $786
Cash And Equivalents FY 2025 · Dec 31, 2024 $862
Stockholders Equity FY 2025 · Dec 31, 2025 −$618.54K
Stockholders Equity FY 2025 · Dec 31, 2024 −$2.3M
Stockholders Equity FY 2025 · Dec 31, 2023 −$1.82M
Current Liabilities FY 2025 · Dec 31, 2025 $619.33K
Current Liabilities FY 2025 · Dec 31, 2024 $2.3M
Total Liabilities FY 2025 · Dec 31, 2025 $619.33K
Total Liabilities FY 2025 · Dec 31, 2024 $2.3M
Current Assets FY 2025 · Dec 31, 2025 $786
Current Assets FY 2025 · Dec 31, 2024 $862
Total Assets FY 2025 · Dec 31, 2025 $786
Total Assets FY 2025 · Dec 31, 2024 $862
Eps Diluted FY 2025 · Dec 31, 2025 −$0.04
Eps Diluted FY 2025 · Dec 31, 2024 −$0.02
Eps Basic FY 2025 · Dec 31, 2025 −$0.04
Eps Basic FY 2025 · Dec 31, 2024 −$0.02
Sga Expense FY 2025 · Dec 31, 2025 $66.95K
Sga Expense FY 2025 · Dec 31, 2024 $67.44K
Net Income FY 2025 · Dec 31, 2025 −$1.29M
Net Income FY 2025 · Dec 31, 2024 −$490.44K